Anticoagulation in COVID-19

Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):260-261. doi: 10.1093/ehjcvp/pvaa036.

Authors

Bassam Atallah^{1

2}, Saad I Mallah³, Wael AlMahmeed⁴

Affiliations

¹ Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates.
² Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
³ School of Medicine, Royal College of Surgeons in Ireland-Bahrain, Kingdom of Bahrain.
⁴ Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants*
Betacoronavirus
COVID-19
China
Coronavirus Infections*
Humans
Inpatients*
Pandemics*
Pneumonia, Viral*
Retrospective Studies
Risk Factors
SARS-CoV-2

Substances

Anticoagulants